Panbela to participate in the 34th annual roth conference

Minneapolis, march 10, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, announced today that management will participate in a fireside chat at the 34th annual roth conference on march 14, 2022, at 11:30am pt. the webcast will be available at: https://wsw.com/webcast/roth43/pbla/1805948
PBLA Ratings Summary
PBLA Quant Ranking